Lipoprotein (a) induces angiogenesis on the chick embryo chorioallantoic membrane

European Journal of Clinical Investigation

Volumn 28, Issue 7, 1998, Pages 533-537

  Ribatti, D ^a   Vacca, A ^a   Giacchetta, F ^b,d   Cesaretti, S ^c   Anichini, M ^c   Roncali, L ^a   Damacco, F ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b CARSO Foundation   (Italy)

^c INRCA   (Italy)

^d CARSO Foundation   (Italy)

Author keywords

Angiogenesis; Atherosclerosis; Chorioallantoic membrane; Lipoprotein(a)

Indexed keywords

GELATIN SPONGE; LIPOPROTEIN A; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHICK EMBRYO; CHORIOALLANTOIS; EMBRYO; MODEL; NONHUMAN; PRIORITY JOURNAL;

ALLANTOIS; ANIMALS; ANTIBODIES, MONOCLONAL; ARTERIOSCLEROSIS; CHICK EMBRYO; CHORION; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEIN(A); MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0031857136     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00322.x     Document Type: Article

References (35)

1. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995; 57: 791-804.
2. Steinberg D, Witzum JL. Lipoproteins and atherogenesis: current concepts. JAMA 1990; 4: 3.
3. Eisenstein R. Angiogenesis in arteries: a review. Pharmacol Ther 1991; 49: 1-19.
4. Williams JH, Armstrong ML, Heistad DD. Vasa vasorum in atherosclerotic coronary arteries responses to vasoactive stimuli and regression of atherosclerosis. Circ Res 1988; 62: 515-23.
5. Barger AC, Beeuwkes R, Lairey L, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathogenesis of atherosclerosis. N Engl J Med 1984; 310; 175-7.
6. O'Brien R, Garwin MR, Dev R, et al. Angiogenesis in human atherosclerotic plaques. Am J Pathol 1994; 145: 883-94; 264: 3047-52.
7. O'Brien R, Garwin MR, Dev R, et al. Angiogenesis in human atherosclerotic plaques. Am J Pathol 1994; 145: 883-94; 264: 3047-52.
8. Schneiderman J, Bordin GM, Engelberg I, et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall: a possible mechanism for aneurysm expression. J Clin Invest 1995; 96: 639-45.
9. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley MJ, Isratel MA, Liotta LA, eds. The Molecular Basis of Cancer. Philadelphia: WB Saunders 1995; 206-32.
10. Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 1991; 115: 209-18.
11. Hajjar KA, Nachman RL. The role of lipoprotein(a) in atherogenesis and thrombogenesis. Ann Rev Med 1996; 47: 423-42.
12. McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987; 330: 132-7.
13. Miles LA, Fless GM, Levine EG, Scanu AM, Plow EF. A potential basis for the thrombotic risk associated with lipoprotein(a). Nature 1989; 339: 301-3.
14. Tyrrel HJ, Cooke T, Reilly M, et al. Lipoprotein (Lp(a)) and peripheral vascular disease. J Intern Med 1992; 232: 349-60.
15. Zenker G, Koltringer P, Bone G, Nienderkorn K, Pfeiffer K, Jurgens G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 1986; 17: 942-50.
16. Mura A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986; 59: 199-208.
17. Woo J, Lau E, Lam CWK, et al. Hypertension, lipoprotein(a), and apolipoprotein A-1 as risk factors for stroke in the Chinese. Stroke 1991; 22: 203-210.
18. Barbir M, Kushwaha S, Hunt B, et al. Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients. Lancet 1992; 340: 1500-01.
19. Hoff HF, Beck GJ, Skibinski CI, et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988; 77: 1239-47.
20. Niendorf A, Rath M, Wolf K, et al. Morphological detection and quantification of lipoprotein (a) deposition in atheromatoid lesions of human aorta and coronary arteries. Virchows Arch A 1990; 417: 105-11.
21. Ribatti D, Vacca A, Roncali L, Dammacco F. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol 1996; 40: 1189-97.
22. Ribatti D, Gualandris A, Bastaki M, et al. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/ chorioallantoic membrane assay. J Vasc Res 1997; 34: 455-63.
23. Olivo M, Bhardway R, Schulze-Osthoff K, Sorg C, Jurgen-Jacob H, Flamme I. A comparative study on the effects of tumor necrosis factor-α (TNF-α), human angiogenic factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo. Anal Rev 1992; 234: 105-15.
24. Elias H, Hyde DM. Stereological measurements of isotropic structures. In: Elias H, Hyde DM, eds. A Guide to Practical Stereology. Basle: Karger 1983; 25-44.
25. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 170: 39-49.
26. Haralabopoulos GC, Grant DS, Kleinman HK, Maragoudakis ME. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol 1997; 273: C239-C245.
27. Harvey VS, Estrella P, Brown LF, Mc Donagh J, Dvorak AM. Fibrin containing gels induce angiogenesis. Lab Invest 1987; 57: 673-86.
28. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. The proliferation of human muscle cells is promoted by lipoprotein(a). Science 1993; 260: 1655-8.
29. Winkles JA, Friesel R, Burgess WH, et al. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor-1 (endothelial cell growth factor). Proc Natl Acad Sci USA 1987; 84: 7124-8.
30. Weich JA, Iberg N, Klagsbrun M, Folkman J. Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells. Growth Factors 1990; 2: 313-20.
31. Ferrara N, Winer J, Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 1991; 5: 141-8.
32. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. J Biol Chem 1991; 266: 11947-54.
33. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992; 181: 902-6.
34. Bo WJ, Mercuri M, Tucker R, Bond MG. The human carotid atherosclerotic plaque stimulates angiogenesis on the chick chorioallantoic membrane. Atherosclerosis 1992; 94: 71-8.
35. Pepper MS. Manipulating angiogenesis. From basic science to the bedside. Arterioscl Thromb Vasc Biol 1997; 17: 605-19.